Global Xerostomia Therapeutics Market Size & Outlook
Global xerostomia therapeutics market, 2018-2030 (US$M)
Related Markets
Global xerostomia therapeutics market highlights
- The global xerostomia therapeutics market generated a revenue of USD 2,158.1 million in 2024 and is expected to reach USD 2,703.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 3.9% by 2030.
- In terms of segment, salivary stimulants accounted for a revenue of USD 789.9 million in 2024.
- Dentifrices is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 2,158.1 million |
| Market revenue in 2030 | USD 2,703.9 million |
| Growth rate | 3.9% (CAGR from 2025 to 2030) |
| Largest segment | Salivary stimulants |
| Fastest growing segment | Dentifrices |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Salivary Stimulants, Salivary Substitutes, Dentifrices |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global xerostomia therapeutics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UAE is the fastest growing regional market and is projected to reach USD 6.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Xerostomia Therapeutics Market Scope
Xerostomia Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Acacia Pharma | View profile | 51-100 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.acaciapharma.com |
| Parnell Pharmaceuticals Holdings Ltd | View profile | 78 | 476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, Australia, 2015 | https://www.parnell.com |
| Pendopharm | View profile | 1001-5000 | Montreal, Quebec, Canada, North America | http://pendopharm.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Colgate-Palmolive Co | View profile | 34000 | 300 Park Avenue, New York, NY, United States, 10022 | https://www.colgatepalmolive.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Church & Dwight Co Inc | View profile | 5550 | 500 Charles Ewing Boulevard, Ewing, NJ, United States, 08628 | https://www.churchdwight.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Global xerostomia therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to xerostomia therapeutics market will help companies and investors design strategic landscapes.
Salivary stimulants was the largest segment with a revenue share of 36.6% in 2024. Horizon Databook has segmented the Global xerostomia therapeutics market based on salivary stimulants, salivary substitutes, dentifrices covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Xerostomia Therapeutics Product Outlook (Revenue, USD Million, 2018-2030)
- Salivary Stimulants
- Salivary Substitutes
- Dentifrices
- Global Xerostomia Therapeutics Type Outlook (Revenue, USD Million, 2018-2030)
- Prescription
- OTC
Reasons to subscribe to Global xerostomia therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global xerostomia therapeutics market databook
-
Our clientele includes a mix of xerostomia therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global xerostomia therapeutics market, including forecasts for subscribers. This global databook contains high-level insights into Global xerostomia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global xerostomia therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Xerostomia therapeutics market size, 2024 (US$M)
Global xerostomia therapeutics market share, by product, 2024 & 2030 (%, US$M)
Xerostomia therapeutics market: Opportunity assessment by country
Global xerostomia therapeutics market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
